Strum, Jay C.
9G1 Therapeutics, Research Triangle Park, North Carolina.
6 papers on CoChatORCID 0009-0005-4870-0983
Most cited papers
- Verified
The Orphan G Protein-coupled Receptors GPR41 and GPR43 Are Activated by Propionate and Other Short Chain Carboxylic Acids
Brown, A. J., Goldsworthy, S. M., Barnes, A. A., Eilert, M. M., Tcheang, L., Daniels, D., Muir, A. I., Wigglesworth, M. J., Kinghorn, I., Fraser, N. J., et al. (2003) · Journal of Biological Chemistry
Receptor Mechanisms and SignalingBiochemical Analysis and Sensing Techniques
Cited by 2,409
- Verified
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation
Deng, J., Wang, E. S., Jenkins, R. W., Li, S., Dries, R., Yates, K., Chhabra, S., Huang, W., Liu, H., Aref, A. R., et al. (2018) · Cancer Discovery
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 770
- Verified
A model of acquired autoresistance to a potent ErbB2 tyrosine kinase inhibitor and a therapeutic strategy to prevent its onset in breast cancer
Xia, W., Bacus, S., Hegde, P., Husain, I., Strum, J., Liu, L., Paulazzo, G., Lyass, L., Trusk, P., Hill, J., et al. (2006) · Proceedings of the National Academy of Sciences
HER2/EGFR in Cancer ResearchBreast Cancer Treatment Studies
Cited by 374
- Verified
Adipose Mitochondrial Biogenesis Is Suppressed in db/db and High-Fat Diet–Fed Mice and Improved by Rosiglitazone
Rong, J. X., Qiu, Y., Hansen, M. K., Zhu, L., Zhang, V., Xie, M., Okamoto, Y., Mattie, M. D., Higashiyama, H., Asano, S., et al. (2007) · Diabetes
Adipose Tissue and MetabolismPeroxisome Proliferator-Activated Receptors
Cited by 335
- Verified
Multiple roles of cyclin-dependent kinase 4/6 inhibitors in cancer therapy
Roberts, P. J., Bisi, J. E., Strum, J. C., Combest, A. J., Darr, D. B., Usary, J. E., Zamboni, W. C., Wong, K.-K., Perou, C. M., & Sharpless, N. E. (2012) · JNCI Journal of the National Cancer Institute
Advanced Breast Cancer TherapiesCancer-related Molecular Pathways
Cited by 255
- Verified
Evaluation of targeted bone marrow arrest by G1T28, a CDK4/6 inhibitor in clinical development to reduce chemotherapy-induced myelosuppression
Roberts, P. J., White, H. S., Sorrentino, J. A., Tadema, H., Sale, M., Tiessen, R. G., Bisi, J. E., Makhuli, K. M., Hoogdalem, E.-J. V., Malik, R. K., et al. (2015) · Journal of Clinical Oncology
Hematopoietic Stem Cell TransplantationNeutropenia and Cancer Infections
Cited by 3
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free